NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders
Awarded by NHS England · 2017-08-21T13:23:11+01:00 · £302,000,000
Description
Invitation to offer for NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. Period of contract: 1st February 2018 to 31st January 2019 with options to extend up to a further 17 months. Total maximum framework agreement period including extensions will be no more than 29 months
- Buyer
- NHS England
- Value
- £302,000,000
- Category (CPV)
- Blood coagulants
- Award date
- 2017-08-21T13:23:11+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.